Thrombosis
From the Journals
Older IBD patients are most at risk of postdischarge VTE
Readmission for venous thromboembolism in patients with inflammatory bowel diseases most often occurs within 60 days of discharge.
Conference Coverage
POP AGE shakes up DAPT in elderly
PARIS – Clopidogrel hailed as P2Y12 inhibitor of choice in older patients with non-ST-elevation ACS.
From the Journals
ASCO VTE guideline update: DOACs now an option for prevention, treatment
Updates to the ASCO guideline for VTE prophylaxis and treatment in cancer patients center largely on recent findings regarding direct...
Conference Coverage
Researchers combine genetic and clinical factors in new VTE risk score
MELBOURNE – A score that combines both genetic and clinical risk factors for VTE in patients with lymphoma may offer a better option than current...
Guidelines
First adult APS recommendations released by European society
MADRID – The EULAR recommendations also cover secondary prevention and management of recurrent episodes and catastrophic APS, for which new...
From the Journals
NOACs benefit early stage chronic kidney disease patients
NOACs reduced risk of several adverse events compared with VKAs in a meta-analysis of chronic kidney disease patients.
Conference Coverage
Risk of atrial fibrillation 900% higher with cancer
MELBOURNE –
Conference Coverage
No reduction in PE risk with vena cava filters after severe injury
MELBOURNE – “Given the cost and risks associated with a vena cava filter, our data suggest that there is no urgency to insert the filter in...
Conference Coverage
Consider bleeding risk with oral anticoagulants in patients with GI cancer
MELBOURNE – Patients with some GI cancers may be at increased risk of bleeding, which can complicate the choice of antithrombotic therapies.
News
FDA expands Doptelet approval to ITP patients with thrombocytopenia
The drug is now indicated for treatment of thrombocytopenia in adults with chronic immune thrombocytopenia (ITP) with insufficient response to...
Conference Coverage
Risk model could help predict VTE in acute leukemia
AMSTERDAM – VTE risk modeling is available for patients with solid tumors, but a similar prognostic tool for leukemia patients has been missing....